annual EBIT:
$220.11M+$21.59M(+10.88%)Summary
- As of today (September 7, 2025), AMPH annual earnings before interest & taxes is $220.11 million, with the most recent change of +$21.59 million (+10.88%) on December 31, 2024.
- During the last 3 years, AMPH annual EBIT has risen by +$135.08 million (+158.88%).
- AMPH annual EBIT is now at all-time high.
Performance
AMPH EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$42.18M+$4.89M(+13.12%)Summary
- As of today (September 7, 2025), AMPH quarterly earnings before interest & taxes is $42.18 million, with the most recent change of +$4.89 million (+13.12%) on June 30, 2025.
- Over the past year, AMPH quarterly EBIT has dropped by -$13.03 million (-23.60%).
- AMPH quarterly EBIT is now -41.96% below its all-time high of $72.68 million, reached on September 30, 2023.
Performance
AMPH quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$181.67M-$13.03M(-6.69%)Summary
- As of today (September 7, 2025), AMPH TTM earnings before interest & taxes is $181.67 million, with the most recent change of -$13.03 million (-6.69%) on June 30, 2025.
- Over the past year, AMPH TTM EBIT has dropped by -$48.22 million (-20.97%).
- AMPH TTM EBIT is now -20.97% below its all-time high of $229.88 million, reached on June 30, 2024.
Performance
AMPH TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
AMPH EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.9% | -23.6% | -21.0% |
| 3 y3 years | +158.9% | +69.9% | +90.3% |
| 5 y5 years | +264.7% | +1543.7% | +2537.1% |
AMPH EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +158.9% | -42.0% | +81.6% | -21.0% | +93.4% |
| 5 y | 5-year | at high | +4292.5% | -42.0% | +1543.7% | -21.0% | +2537.1% |
| alltime | all time | at high | +803.1% | -42.0% | +514.1% | -21.0% | +664.2% |
AMPH EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $42.18M(+13.1%) | $181.67M(-6.7%) |
| Mar 2025 | - | $37.29M(-17.4%) | $194.70M(-5.2%) |
| Dec 2024 | $220.11M(+10.9%) | $45.14M(-20.9%) | $205.42M(-4.1%) |
| Sep 2024 | - | $57.05M(+3.3%) | $214.25M(-6.8%) |
| Jun 2024 | - | $55.22M(+15.0%) | $229.88M(+7.3%) |
| Mar 2024 | - | $48.01M(-11.1%) | $214.26M(+7.3%) |
| Dec 2023 | $198.52M(+68.4%) | $53.98M(-25.7%) | $199.69M(+8.8%) |
| Sep 2023 | - | $72.68M(+83.5%) | $183.54M(+36.9%) |
| Jun 2023 | - | $39.60M(+18.4%) | $134.09M(+12.4%) |
| Mar 2023 | - | $33.43M(-11.6%) | $119.32M(+11.0%) |
| Dec 2022 | $117.89M(+38.7%) | $37.83M(+62.9%) | $107.50M(+14.4%) |
| Sep 2022 | - | $23.23M(-6.4%) | $93.93M(-1.6%) |
| Jun 2022 | - | $24.82M(+14.8%) | $95.47M(+17.6%) |
| Mar 2022 | - | $21.61M(-10.9%) | $81.20M(+16.2%) |
| Dec 2021 | $85.02M(+1596.7%) | $24.26M(-2.1%) | $69.90M(+43.8%) |
| Sep 2021 | - | $24.77M(+134.6%) | $48.59M(+77.7%) |
| Jun 2021 | - | $10.56M(+2.5%) | $27.34M(+97.3%) |
| Mar 2021 | - | $10.31M(+248.2%) | $13.86M(+25.6%) |
| Dec 2020 | $5.01M(-91.7%) | $2.96M(-15.8%) | $11.04M(+37.9%) |
| Sep 2020 | - | $3.52M(-220.4%) | $8.00M(+16.2%) |
| Jun 2020 | - | -$2.92M(-139.1%) | $6.89M(-36.1%) |
| Mar 2020 | - | $7.48M(<-9900.0%) | $10.78M(+8069.7%) |
| Dec 2019 | $60.35M(-723.2%) | -$73.00K(-103.0%) | $132.00K(-92.5%) |
| Sep 2019 | - | $2.40M(+147.1%) | $1.75M(-7.7%) |
| Jun 2019 | - | $973.00K(-130.7%) | $1.90M(-194.0%) |
| Mar 2019 | - | -$3.17M(-305.3%) | -$2.02M(-76.6%) |
| Dec 2018 | -$9.68M | $1.54M(-39.4%) | -$8.62M(-27.6%) |
| Sep 2018 | - | $2.55M(-186.7%) | -$11.91M(-31.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | -$2.94M(-69.9%) | -$17.28M(+42.2%) |
| Mar 2018 | - | -$9.78M(+460.0%) | -$12.16M(+235.9%) |
| Dec 2017 | $2.08M(-86.7%) | -$1.75M(-38.1%) | -$3.62M(-46.1%) |
| Sep 2017 | - | -$2.82M(-229.1%) | -$6.71M(-453.0%) |
| Jun 2017 | - | $2.19M(-276.4%) | $1.90M(-81.3%) |
| Mar 2017 | - | -$1.24M(-74.4%) | $10.16M(-36.9%) |
| Dec 2016 | $15.65M(-266.9%) | -$4.84M(-183.5%) | $16.09M(-54.6%) |
| Sep 2016 | - | $5.80M(-44.5%) | $35.43M(+36.9%) |
| Jun 2016 | - | $10.44M(+122.6%) | $25.89M(+392.1%) |
| Mar 2016 | - | $4.69M(-67.6%) | $5.26M(-178.6%) |
| Dec 2015 | -$9.38M(-46.5%) | $14.50M(-487.3%) | -$6.69M(-76.2%) |
| Sep 2015 | - | -$3.74M(-63.2%) | -$28.14M(-12.6%) |
| Jun 2015 | - | -$10.19M(+40.3%) | -$32.20M(+40.0%) |
| Mar 2015 | - | -$7.26M(+4.5%) | -$23.00M(+31.1%) |
| Dec 2014 | -$17.54M(-196.4%) | -$6.95M(-11.0%) | -$17.54M(+132.4%) |
| Sep 2014 | - | -$7.80M(+689.9%) | -$7.55M(-1646.5%) |
| Jun 2014 | - | -$988.00K(-45.3%) | $488.00K(-96.4%) |
| Mar 2014 | - | -$1.80M(-159.2%) | $13.46M(-23.6%) |
| Dec 2013 | $18.18M(-31.8%) | $3.05M(+1220.3%) | $17.61M(-14.2%) |
| Sep 2013 | - | $231.00K(-98.1%) | $20.54M(-23.2%) |
| Jun 2013 | - | $11.98M(+409.4%) | $26.73M(+24.6%) |
| Mar 2013 | - | $2.35M(-60.6%) | $21.45M(-22.0%) |
| Dec 2012 | $26.66M(-185.2%) | - | - |
| Dec 2012 | - | $5.97M(-7.0%) | $27.49M(+27.8%) |
| Sep 2012 | - | $6.42M(-4.1%) | $21.52M(+42.6%) |
| Jun 2012 | - | $6.70M(-20.1%) | $15.09M(+79.9%) |
| Mar 2012 | - | $8.39M | $8.39M |
| Dec 2011 | -$31.30M | - | - |
FAQ
- What is Amphastar Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Amphastar Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Amphastar Pharmaceuticals, Inc.?
- What is Amphastar Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Amphastar Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of AMPH is $220.11M
What is the all time high annual EBIT for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $220.11M
What is Amphastar Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, AMPH annual earnings before interest & taxes has changed by +$21.59M (+10.88%)
What is Amphastar Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of AMPH is $42.18M
What is the all time high quarterly EBIT for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $72.68M
What is Amphastar Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, AMPH quarterly earnings before interest & taxes has changed by -$13.03M (-23.60%)
What is Amphastar Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of AMPH is $181.67M
What is the all time high TTM EBIT for Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $229.88M
What is Amphastar Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, AMPH TTM earnings before interest & taxes has changed by -$48.22M (-20.97%)